We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

105 hedge funds and large institutions have $820M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 37 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,325% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 4

721% more capital invested

Capital invested by funds: $99.9M → $820M (+$720M)

363% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 8

102% more funds holding

Funds holding: 52 → 105 (+53)

62% less call options, than puts

Call options by funds: $661K | Put options by funds: $1.73M

Holders
105
Holders Change
+53
Holders Change %
+101.92%
% of All Funds
1.51%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
57
Increased
37
Reduced
8
Closed
4
Calls
$661K
Puts
$1.73M
Net Calls
-$1.07M
Net Calls Change
-$1.07M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$71.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$62.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$46.6M
4
FCM
Farallon Capital Management
California
+$30.1M
5
CAM
Cormorant Asset Management
Massachusetts
+$21.8M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$21.4M
2
Ensign Peak Advisors
Ensign Peak Advisors
Utah
-$1.82M
3
UOC
UBS O'Connor
Illinois
-$1.51M
4
BFM
Boothbay Fund Management
New York
-$1.4M
5
JP Morgan Chase
JP Morgan Chase
New York
-$644K
Name Holding Trade Value Shares
Change 		Change in
Stake
ABG
26
Ally Bridge Group
New York
$5.84M +$5.9M +270,559 New
SSA
27
Schonfeld Strategic Advisors
New York
$5.03M +$3.07M +140,670 +152%
Northern Trust
28
Northern Trust
Illinois
$4.74M +$1.45M +66,592 +44%
AIC
29
AWM Investment Company
New York
$4.57M +$4.61M +211,518 New
Walleye Capital
30
Walleye Capital
New York
$4.28M +$3.47M +158,946 +404%
Alyeska Investment Group
31
Alyeska Investment Group
Illinois
$4.06M +$4.1M +187,879 New
ACM
32
Altium Capital Management
New York
$3.67M +$3.71M +170,000 New
EI
33
EAM Investors
California
$3.38M +$3.41M +156,565 New
Citadel Advisors
34
Citadel Advisors
Florida
$3.18M +$3.21M +147,323 New
TD Asset Management
35
TD Asset Management
Ontario, Canada
$3.04M +$1.02M +46,766 +50%
N
36
Nuveen
North Carolina
$3.02M +$2.52M +115,549 +475%
PIM
37
Platinum Investment Management
Australia
$2.74M – – –
NFGH
38
Nan Fung Group Holdings
Hong Kong
$2.55M +$2.58M +118,255 New
JGC
39
J. Goldman & Co
New York
$2.49M +$2.52M +115,480 New
Two Sigma Investments
40
Two Sigma Investments
New York
$2.31M +$2.33M +106,885 New
MIM
41
Monashee Investment Management
Massachusetts
$2.16M +$2.18M +100,000 New
Bank of America
42
Bank of America
North Carolina
$1.97M +$1.59M +72,788 +393%
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.81M +$907K +41,581 +98%
Morgan Stanley
44
Morgan Stanley
New York
$1.8M +$434K +19,912 +31%
WP
45
Woodline Partners
California
$1.75M +$1.76M +80,920 New
Prudential Financial
46
Prudential Financial
New Jersey
$1.74M +$1.75M +80,350 New
Renaissance Technologies
47
Renaissance Technologies
New York
$1.54M +$1.56M +71,400 New
BCM
48
Bridgeway Capital Management
Texas
$1.51M – – –
Bank of New York Mellon
49
Bank of New York Mellon
New York
$1.49M +$505K +23,138 +51%
LCM
50
Laurion Capital Management
New York
$1.48M +$1.02M +46,645 +213%
1
2
3 4 5

LBPH Hedge Fund Activity: Q1 2024 in Review

105 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q1 2024, worth a combined $820M — up 721% from $99.9M a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new LBPH positions and 4 closed out — a net gain of 53 holders — while 37 added to existing stakes and 8 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $71.7M. The largest seller was Ikarian Capital, cutting an estimated $21.4M.

  • 105 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q1 2024, up from 52 in Q4 2023.
  • Funds reported $820M of Longboard Pharmaceuticals, Inc. Common Stock stock for Q1 2024, up 721% quarter-over-quarter.
  • 57 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q1 2024 and 4 closed out, a net change of +53 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q1 2024 was RA Capital Management, an estimated $71.7M added.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q1 2024 was Ikarian Capital, an estimated $21.4M sold.

Based on aggregated 13F filings for Q1 2024.